"These GLP-1 agonists can be a two-in-one solution for diabetes and weight loss," Robert Fontana, MD, a Michigan Medicine hepatologist said in an online interview included in the Cure report, "maybe a three-in-one solution if they prove to be safe and effective for metabolic associated steatohepatitis as well." Troubling Pattern in Patient Adherence to GLP-1 Drug Therapy Despite their effectiveness, adhering to the injectable drugs have proven challenging
Epitalon (insomnia)
Chart prep ~10 minutes under 2 step 2 Act in clicks, not hours Order the labs, interpret results, build the plan, and give patients access to trusted supplements all in the time it used to take to find the right browser tab
Int J Nanomed 8:18171823
GHK-Cu functions at the molecular level by affecting gene expression and cellular pathways involved in tissue repair, inflammation control, and oxidative stress reduction
Between 50% and 57% of those on the highest dose achieved 20% or greater weight loss